VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,584,053 | -38.8% | 5,261,392 | -31.6% | 0.11% | -30.3% |
| Q2 2023 | $231,499,855 | -44.6% | 7,688,471 | -40.5% | 0.15% | -48.1% |
| Q1 2023 | $417,739,037 | +181.9% | 12,913,108 | +149.7% | 0.29% | +148.3% |
| Q4 2022 | $148,212,805 | -14.1% | 5,171,417 | -27.7% | 0.12% | -4.1% |
| Q3 2022 | $172,572,000 | +18.8% | 7,154,690 | +34.9% | 0.12% | +13.9% |
| Q2 2022 | $145,243,000 | -32.1% | 5,304,719 | -5.0% | 0.11% | -16.3% |
| Q1 2022 | $214,036,000 | -57.8% | 5,581,098 | -64.7% | 0.13% | -52.6% |
| Q4 2021 | $507,055,000 | +23.0% | 15,830,629 | +13.2% | 0.27% | +11.9% |
| Q3 2021 | $412,121,000 | +18.3% | 13,984,453 | +36.4% | 0.24% | +16.3% |
| Q2 2021 | $348,270,000 | -3.7% | 10,249,247 | -7.9% | 0.21% | -10.7% |
| Q1 2021 | $361,793,000 | +7.4% | 11,132,049 | +19.1% | 0.23% | +17.6% |
| Q4 2020 | $336,774,000 | -46.5% | 9,349,650 | -41.8% | 0.20% | -51.5% |
| Q3 2020 | $629,421,000 | +78.4% | 16,073,032 | +67.1% | 0.41% | +49.1% |
| Q2 2020 | $352,825,000 | +74.5% | 9,619,005 | +9.6% | 0.28% | +50.3% |
| Q1 2020 | $202,196,000 | -71.8% | 8,775,883 | -64.2% | 0.18% | -64.7% |
| Q4 2019 | $717,530,000 | +140.2% | 24,505,792 | +119.1% | 0.52% | +119.9% |
| Q3 2019 | $298,690,000 | +3.7% | 11,182,696 | -0.8% | 0.24% | +1.7% |
| Q2 2019 | $288,015,000 | -29.0% | 11,268,188 | -37.7% | 0.23% | -40.7% |
| Q1 2019 | $405,698,000 | -29.2% | 18,095,362 | -33.4% | 0.39% | -32.6% |
| Q4 2018 | $573,314,000 | +11.3% | 27,184,179 | -2.3% | 0.58% | +26.4% |
| Q3 2018 | $515,098,000 | -8.7% | 27,813,019 | +10.0% | 0.46% | -11.6% |
| Q2 2018 | $564,290,000 | -31.0% | 25,293,144 | -32.0% | 0.52% | -22.9% |
| Q1 2018 | $817,469,000 | +31.2% | 37,191,465 | +38.7% | 0.67% | +34.6% |
| Q4 2017 | $623,038,000 | +2.9% | 26,808,814 | +1.7% | 0.50% | +1.0% |
| Q3 2017 | $605,391,000 | +10.3% | 26,367,152 | +6.1% | 0.50% | 0.0% |
| Q2 2017 | $548,773,000 | -15.5% | 24,853,804 | -12.7% | 0.50% | -14.5% |
| Q1 2017 | $649,661,000 | +12.7% | 28,481,420 | +3.3% | 0.58% | +11.3% |
| Q4 2016 | $576,675,000 | -46.0% | 27,565,747 | -31.8% | 0.52% | -47.9% |
| Q3 2016 | $1,068,116,000 | +204.4% | 40,413,040 | +219.0% | 1.00% | +178.8% |
| Q2 2016 | $350,919,000 | – | 12,668,528 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |